Late presentation of acromegaly in medically controlled prolactinoma patients.
Manuylova E, Calvi LM, Hastings C, Vates GE, Johnson MD, Cave WT Jr, Shafiq I.
Manuylova E, et al. Among authors: vates ge.
Endocrinol Diabetes Metab Case Rep. 2016;2016:16-0069. doi: 10.1530/EDM-16-0069. Epub 2016 Oct 17.
Endocrinol Diabetes Metab Case Rep. 2016.
PMID: 27855229
Free PMC article.
Given the possibility of mixed GH and PRL co-secretion, the current recommendation is to obtain an insulin-like growth factor-1 (IGF-1) in patients with prolactinoma at the initial diagnosis. Long-term follow-up of IGF-1 is not routinely done. Here, we report two cases of …
Given the possibility of mixed GH and PRL co-secretion, the current recommendation is to obtain an insulin-like growth factor-1 (IGF-1) in p …